In pursuant to regulation 47 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Panchsheel Organics has informed that it enclosed a copy of ‘Newspaper Advertisement’, regarding publication of extract of Standalone Un-Audited Financial Results for quarter ended on 30th June, 2024, which was approved in the meeting of the Board of Directors of the Company held on Thursday, 14th August, 2024, Published on 15th August, 2024 in Free Press (English Edition) & Choutha Sansar (Hindi Edition).
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1825.35 |
| Dr. Reddys Lab | 1315.20 |
| Cipla | 1315.60 |
| Zydus Lifesciences | 904.55 |
| Lupin | 2328.75 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: